Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens

Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens

Systemic sclerosis (SSc)-related Raynaud’s phenomenon (RP) and digital ulcers (DU) can impair health-related quality of life (HRQoL). The aim of our study was to estimate HRQoL in SSc patients treated with two different intravenous (IV) iloprost (ILO) regimens and in patients not treated with IV ILO...

Full description

Bibliographic Details
Main Authors: T. Schioppo, L. Scalone, P. Cozzolino, L. Mantovani, G. Cesana, O. De Lucia, A. Murgo, F. Ingegnoli
Format: Article
Language:English
Published: PAGEPress Publications 2019-07-01
Series:Reumatismo
Subjects:
Iloprost
prostacyclin
systemic sclerosis
health related quality of life
EQ-5D-5L
Online Access:https://www.reumatismo.org/index.php/reuma/article/view/1190

Similar Items

Similar Items